Cotinga Pharmaceuticals Inc.
COTQF
$0.0001
$0.000.00%
OTC PK
| 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | 01/31/2019 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 61.76% | 46.90% | 36.30% |
| Total Depreciation and Amortization | -- | -- | 5.18% | -4.62% | -78.34% |
| Total Amortization of Deferred Charges | -- | -- | -92.57% | -96.34% | -7.73% |
| Total Other Non-Cash Items | -- | -- | -54.05% | 164.17% | 419.57% |
| Change in Net Operating Assets | -- | -- | 20.19% | -60.98% | 92.57% |
| Cash from Operations | -- | -- | 80.16% | 58.50% | 56.44% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -141.53% | -101.08% | -98.45% |
| Cash from Investing | -- | -- | -138.19% | -101.06% | -98.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -2.70% | -2.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 84.40% | -1,366.14% | -124.98% |
| Cash from Financing | -- | -- | -93.58% | -13.57% | -11.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -138.48% | 125.94% | 54.23% |